Therapeutics News and Research

RSS

Existing drugs could help prevent deadly familial stomach and lobular breast cancers

Deadly familial stomach and lobular breast cancers could be successfully treated at their earliest stages, or even prevented, by existing drugs that have been newly identified by cancer genetics researchers at New Zealand's University of Otago.

23 Mar 2015

Researchers identify new role for VEGFA that may help target metastatic neuroblastoma

Healthy bone is continuously involved in a dynamic process that includes bone deposition and bone resorption.

23 Mar 2015

University of Manitoba professors, brain experts discuss how concussions affect the brain

University of Manitoba professors and brain experts are gathering at McNally Robinson Booksellers on March 18 to have a lively, interactive panel discussion on how concussions affect the brain.

20 Mar 2015

Sandia biosciences technologies could soon find their way into doctors' offices

Technologies developed in Sandia National Laboratories' biosciences program could soon find their way into doctors' offices -- devices like wearable microneedles that continuously analyze electrolyte levels and a lab-on-a-disk that can test a drop of blood for 64 different diseases in minutes.

20 Mar 2015

UF pharmacy dean to be honored with 2015 SURA Distinguished Scientist Award

SURA today announced that Julie A. Johnson, Dean and Distinguished Professor at the University of Florida's College of Pharmacy, will receive its 2015 SURA Distinguished Scientist Award.

20 Mar 2015

Neurology Times features special coverage of MS in observance of MS Awareness Month

UBM Medica US announces that Neurology Times, a leading online community and information resource for neurologists and other healthcare providers, is featuring special coverage of multiple sclerosis in observance of MS Awareness Month.

19 Mar 2015

New pre-clinical, clinical data for IMBRUVICA to be highlighted at AACR Annual Meeting

Pharmacyclics, Inc. today announced that new pre-clinical and clinical data for ibrutinib (IMBRUVICA) will be highlighted at the 2015 American Association for Cancer Research Annual Meeting to be held April 18 – 22, 2015, in Philadelphia, PA.

19 Mar 2015

ImmunoCellular, PharmaCell sign manufacturing agreement for European production of ICT-107

ImmunoCellular Therapeutics, Ltd. today announced the establishment of an agreement with PharmaCell B.V. to provide contract manufacturing services for the European production of ICT-107, a dendritic cell-based cancer immunotherapy in development as a potential treatment for glioblastoma (GBM).

19 Mar 2015

Life Science Leader recognizes CMC Biologics for quality, reliability for third consecutive year

CMC Biologics, Inc., a leading global contract manufacturing organization known for technical excellence and customer satisfaction in biopharmaceutical development and commercial manufacture of protein-based therapeutics, was recognized for the third consecutive year for quality and reliability by Life Science Leader at an awards ceremony at DCAT Week '15 in New York.

19 Mar 2015

New radiation treatment for brain cancer implanted in first human being at CTRC

David Williams is the first human being ever to have a new radiation treatment implanted in the center of his brain tumor.

18 Mar 2015

Researchers reveal how omega-3 fatty acids inhibit growth of prostate cancer cells

Washington State University researchers have found a mechanism by which omega-3 fatty acids inhibit the growth and spread of prostate cancer cells. The findings, which are at odds with a 2013 study asserting that omega-3s increase the risk of prostate cancer, point the way to more effective anti-cancer drugs.

18 Mar 2015

Physicians, researchers to discuss advances in cancer immunotherapies at UChicago symposium

The Ben May Department for Cancer Research at the University of Chicago will hold a day-long symposium on cancer immunotherapy for physicians and researchers.

18 Mar 2015

New study finds that prices of leading cancer drugs increased by 10% annually since 1995

The prices of leading cancer drugs have risen at rates far outstripping inflation over the last two decades, according to a new study co-authored by an MIT economist -- but the exact reasons for the cost increases are unclear.

18 Mar 2015

Global breast cancer therapeutics market estimated to reach $13.38 billion in 2018

Despite the availability of approximately 25 drugs for the treatment of breast cancer, the unmet need in the global market is vast. To address this drawback, pharmaceutical companies have established a robust pipeline that currently has about 52 drugs in development. While chemotherapy remains the most important class of drugs for breast cancer treatment, the trend toward targeted drugs is on the rise.

17 Mar 2015

Ludwig researchers establish proof of concept for new approach to drug design

Exploring the fundamental mechanism by which a cell-surface receptor transmits its signal, an international team of Ludwig researchers and their colleagues has established proof of concept for an entirely new approach to drug design. They report that a class of synthetic molecules known as diabodies can, from outside the cell, latch onto a target receptor and manipulate it in such a manner as to induce distinct and varying effects within cells and tissues.

17 Mar 2015

Comprehensive review of sex hormones' role in female reproductive tract

Charles R. Wira, PhD, and colleagues at Dartmouth's Geisel School of Medicine have presented a comprehensive review of the role of sex hormones in the geography of the female reproductive tract and evidence supporting a "window of vulnerability" to HIV and other sexually transmitted infections (STIs).

17 Mar 2015

NantWorks, Sorrento collaborate to discover and develop novel anti-cancer immunotherapies

NantWorks, Inc. and Sorrento Therapeutics, Inc., announced today that they have entered into a binding agreement to initiate a global collaboration to discover and develop novel anti-cancer immunotherapies derived from Sorrento's proprietary G-MAB library against neoepitopes of tumor-specific antigens discovered using NantWorks' proprietary pan-omics based, precision medicine approach.

16 Mar 2015

Therapeutics News and Research

Existing drugs could help prevent deadly familial stomach and lobular breast cancers

Researchers identify new role for VEGFA that may help target metastatic neuroblastoma

University of Manitoba professors, brain experts discuss how concussions affect the brain

Sandia biosciences technologies could soon find their way into doctors' offices

UF pharmacy dean to be honored with 2015 SURA Distinguished Scientist Award

Neurology Times features special coverage of MS in observance of MS Awareness Month

New pre-clinical, clinical data for IMBRUVICA to be highlighted at AACR Annual Meeting

ImmunoCellular, PharmaCell sign manufacturing agreement for European production of ICT-107

Life Science Leader recognizes CMC Biologics for quality, reliability for third consecutive year

New radiation treatment for brain cancer implanted in first human being at CTRC

Researchers reveal how omega-3 fatty acids inhibit growth of prostate cancer cells

Physicians, researchers to discuss advances in cancer immunotherapies at UChicago symposium

New study finds that prices of leading cancer drugs increased by 10% annually since 1995

Global breast cancer therapeutics market estimated to reach $13.38 billion in 2018

Ludwig researchers establish proof of concept for new approach to drug design

Comprehensive review of sex hormones' role in female reproductive tract

NantWorks, Sorrento collaborate to discover and develop novel anti-cancer immunotherapies

Ruthigen, Pulmatrix sign definitive merger agreement

Guanabenz drug prevents myelin loss, alleviates symptoms of MS in animal models

'Turbocharged' protein holds promise in hemophilia gene therapy

Advancing therapeutic biopolymer development eBook

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News